Your organization’s
knowledge is its
most valuable asset.
We make it AI-ready at scale, then run R&D on top of it without your science leaving your control.
Two teams derive the same result a year apart and neither ever knows. The work was done, paid for and recorded, and it still had to happen twice.
Built from the record up
A record that holds claims, not documents
Every assertion is its own row, carrying who made it, when, what it rests on and whether it still stands. Two sources agreeing is a count. Two sources disagreeing is a record, not an average. Retract a source and what depended on it is visible.
ProofThe Attest report ↗AttestDB is open source ↗
0 of 1,148 citations pointed at a record outside the question asked. Standard retrieval missed 32 of 4,156.
- assertedsilencing stops the tears
- contestedflavour never panel-tested
- extendedthree food-safe compounds
Your teams keep the tools. Your IP stays inside
People are already pasting unpublished methods into consumer chatbots, because that is where the useful tool is. Policy sits at the record, not at the person: an agent can rank a hypothesis on a restricted assay result without that result ever reaching the model or the reader.
StatusIngress control is live. Reasoning and egress policy are on the roadmap.
Agents work the whole of R&D, on one state
Discovery through clinical, every stage reading the same record and writing its result back to it. Because they share a state rather than a chat history, a conclusion found in one program is available to the next question asked in another.
ProofTwo published runs, and the third path neither set out to find ↗
It arrives in the tool already open
Omic Discover for the full investigation, and the same fabric over MCP inside Claude and ChatGPT. Nobody is asked to move, so knowledge accrues as a byproduct of the work rather than as a second job.
ProofSeven papers, a patent and 16 candidates from one archive ↗
Ask where you already work.
Answer from everything you know.
Can we stop onion tears without touching the onion?
The seven papers
Six are published in full below. The seventh is under double-blind review, and the patent will be shown once filed.
- technical reportAttest: a claim-native data layer for shared knowledge
- technical reportA survey of 3,974 archaeal biosynthetic gene clusters, and a substrate predictor for the fraction tools can see
- preprintMERIT: predicting trial outcomes from mechanism, not from compound memorization
- technical reportNear-cognate decoys hide partner identity in disordered-region benchmarks
- technical reportPRESTO: one model for binding affinity, and where it stops working
- technical reportSeven silent failure modes in genome-mining pipelines
- Under double-blind reviewTitle held until the review closes.